This document provides an overview of pathology of the esophagus. It begins with normal anatomy and histology of the esophagus. It then discusses various congenital and acquired malformations, lesions associated with motor dysfunction, different types of esophagitis, Barrett's esophagus, esophageal varices, benign and malignant neoplasms. In particular, it provides detailed descriptions of conditions such as achalasia, hiatal hernia, Barrett's esophagus, highlighting their pathogenesis, clinical features, histopathology, and importance.
Different esophageal disorders are discussed in this lecture. The learning objectives are to understand:
The anatomy and physiology of the oesophagus and their relationship to disease.
The clinical features, investigations, and treatment of benign and malignant disease with particular reference to the common adult disorders.
Topics include: Surgical anatomy, Physiology, Symptoms, Investigations, Congenital lesions: TOF and Atresia, Benign tumours, Cancer of oesophagus, Foreign bodies,Oesophageal perforation, Gastro-oesophageal reflux diease, Hiatal hernia,
Oesophageal motility disorders: achalasia and diffuse spasm, Oesophgeal diverticula.
and Others.
This is a powerpoint slideshow discussing some of the commonest disorders of colon; namely Hirschsprung's disease, Diverticular diseases of colon, ulcerative colitis, pseudomembranous colitis and ischemic colitis.
Different esophageal disorders are discussed in this lecture. The learning objectives are to understand:
The anatomy and physiology of the oesophagus and their relationship to disease.
The clinical features, investigations, and treatment of benign and malignant disease with particular reference to the common adult disorders.
Topics include: Surgical anatomy, Physiology, Symptoms, Investigations, Congenital lesions: TOF and Atresia, Benign tumours, Cancer of oesophagus, Foreign bodies,Oesophageal perforation, Gastro-oesophageal reflux diease, Hiatal hernia,
Oesophageal motility disorders: achalasia and diffuse spasm, Oesophgeal diverticula.
and Others.
This is a powerpoint slideshow discussing some of the commonest disorders of colon; namely Hirschsprung's disease, Diverticular diseases of colon, ulcerative colitis, pseudomembranous colitis and ischemic colitis.
Gallstones:
Most common biliary pathology
Asymptomatic in majority of cases (>80%)
Approx. 1–2% of asymptomatic patients develop symptoms requiring cholecystectomy per year.
Servikal İntraepitelyal Neoplazilerde (CIN) Yönetim nasıl olmalıdır?
HPV virüsü tipi takipte önemli midir? CIN1, CIN2 ve CIN3 te tedavi yöntemi ne olmalıdır?
Gallstones:
Most common biliary pathology
Asymptomatic in majority of cases (>80%)
Approx. 1–2% of asymptomatic patients develop symptoms requiring cholecystectomy per year.
Servikal İntraepitelyal Neoplazilerde (CIN) Yönetim nasıl olmalıdır?
HPV virüsü tipi takipte önemli midir? CIN1, CIN2 ve CIN3 te tedavi yöntemi ne olmalıdır?
New Treatments for GERD and Barrett's EsophagusSummit Health
Learn the symptoms of Gastroesophageal Reflux Disease (GERD) and Barrett’s esophagus, and when they may warrant further medical attention. Hear the latest in treatment methods, including radio frequency ablation and endoscopic ultrasound.
This presentation summarizes the state of the art with respect to the management of GIST. It covers the basics of surgical and medical management including the role of neoadjuvant and adjuvant targeted therapy. www.ellenhornmd.com
This presentation explains in detail the definition, pathophysiology, signs & symptoms, management, and prognosis of intestinal obstruction, ileus, and volvulus.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. Outline of Content
•
•
•
•
•
•
•
•
Normal anatomy and histology
Congenital and acquired malformations
Lesions associated with motor dysfunction
Esophagitis
Barrett esophagus
Esophageal varices
Benign neoplasms and tumor-like lesions
Malignant neoplasms and staging
3. Normal
anatomy/physiology
Muscular tube from pharynx (C6) to
esophageal-gastric junction, about 25 cm long
• Endoscopy: defined as 15-40 cm from incisor
teeth
• Two areas of increased intraluminal pressure
that normally remain contracted at rest:
•
Upper esophageal sphincter: 3 cm segment at
cricopharyngeus muscle
• Lower esophageal sphincter (LES): 3-5 cm segment
of thickened smooth muscle around diaphragmatic
esophageal hiatus, just proximal to histologic EG
junction
•
4. Normal Histology and Pathologic Correlations
•
•
•
•
•
•
•
Mucosa: nonkeratinized squamous;
basal zone is 10-15% of thickness
Lymphocytes: CD8 T cells in
epithelium; CD4 T cells and B cells
in lamina propria
Muscularis mucosa: smooth muscle
between mucosa and submucosa
Submucosal mucous glands:
mainly proximal & distal esophagus
Muscularis propria: skel. muscle
upper 1/3 (voluntary swallow); sm.
muscle lower 1/3; middle 1/3
mixed
Myenteric nerve plexus: between
circular inner and longitudinal
outer layers of muscularis propria
Serosa: mostly absent, facilitating
spread of invasive tumors or
infections into mediastinum
7. Congenital Malformations
Ectopias; About 4% of persons by endoscopic exam
“inlet patch” of gastric-type epithelium replaces
squamous, just below upper esophageal sphincter
•
Atresias; atresia = segment reduced to thin cord, no
lumen
•
• 1/1000 live births
•
• usually near tracheal bifurcation, usually with
associated tracheal-esophageal fistula
•
• mechanism: failed septation of foregut
•
• symptoms: regurgitation, paroxysmal choking,
aspiration of liquid into lungs
9. Atresia and tracheoesophageal fistula:
5 types
Which two cause
paroxysms of
coughing upon
baby’s first feeding?
B
A
________
Which one is the most
common type, and
causes immediate
regurgitation upon
baby’s first feeding?
_________
C
D
E
All need immediate
surgical correction
10. Congenital & Acquired
Malformations
Stenoses:(narrowing of a duct or passage)Usually
acquired due to chronic gastro-esophageal reflux,
radiation, or ingested caustic substances; result in
progressive dysphagia
Duplications: • congenital duplication cysts of
60% occur in lower
esophagus
• Lined by epithelium (squamous, gastric, or respiratory
type) with smooth muscle wall
• Imaging studies: differential diagnosis includes other
thoracic cysts (bronchogenic, thymic, thyroidal)
11. Acquired Malformations
•
Webs: • usually women > 40 years old
• web: a mucosal fold (2-4 mm thick)
•
which protrudes into the lumen, causing dysphagia with
solid foods
•
Plummer-Vinson syndrome
• dysphagia due to upper esophageal web + Fe deficiency
anemia + glossitis
•
• mucosal abnormalities: glossitis and angular stomatitis
(mouth) secondary to mucosal atrophy associated with Fe
lack
• in P-V
syndrome, chronic iron-deficiency anemia precedes
development of web, but how or whether Fe deficiency
causes the web to form is controversial
• associated with increased risk for
squamous carcinoma in oral cavity, hypopharynx, and
esophagu
13. Plummer-Vinson syndrome:
potential sequela
upper esophageal web
Endoscopic view of
esophagus: ulcerated and
nodular mass
What is the most likely
What is the most likely
diagnosis for this mass
diagnosis for this mass
lesion?
lesion?
Courtesy www.gastrointestinalatlas.com
14. Schatzki’s Ring
Circumferential ring in lower esophagus near EG junction; thicker than
webs (may contain hyperplastic muscularis propria) dysphagia
barium swallow esophagram
endoscopic view
15. Lesions affecting motor function
Achalasia
Zenker
diverticulum
Sliding
hiatal
hernia
Epiphrenic
diverticulum
Rolling
hiatal
hernia
MalloryWeiss
tear
16. Diverticula
Definition: outpouching comprised of
all visceral layers (mucosa, submucosa,
muscularis)
• Sites: hypopharynx, thoracic,
epiphrenic
• Pathogenesis
•
Congenital: embryologic defect
• Traction: fibrous scarring of soft tissue
adherent to serosa, pulling wall of
esophagus outward
• Pulsion: unclear mechanism; potentially
weak area at junction of pharyngeal
constrictors (Killian’s triangle) allowing
diverticulum to develop in response to
increased intraluminal pressure.
•
17. Zenker’s Diverticulum
•
•
•
•
•
•
27 cases described in 1877 by Zenker &
Ziemssen
Most common esophageal diverticulum
Pathogenesis: pulsion explanation favored
(increased pressure in lumen forces tissue
through weak spot in muscle layer)
Location: hypopharynx of older persons
(superior to upper esophageal sphincter)
May become large and sequester food,
with regurgitation or mass effect in the
neck
Treatment: surgical resection of larger
lesions
19. Less common diverticula
•
•
Traction
• Usually small, mid-esophagus
• Few symptoms
• Pathogenesis: uncertain; motor disorder or postinflammatory fibrosis
Epiphrenic
• Just above LES, may be wide-mouthed; 1-10 cm.
diameter
• Pathogenesis: majority of patients have motility
disorder (achalasia or diffuse esophageal spasm)
• Symptoms: nocturnal regurgitation of large volumes
of fluid
• Treatment: resection large ones; address motor
disorder
21. Achalasia
•
Swallowing disorder defined by 3 major problems
•
Aperistalsis
•
Incomplete relaxation LES with swallowing
•
Increased resting tone of LES (impaired relaxation)
•
Pathogenesis: normally, distal inhibitory neurons and interruption of
cholinergic signals allow relaxation of LES. Degenerative failure of
inhibitory neurons impaired relaxation. Usually primary (idiopathic),
but also secondary to malignancy, amyloidosis, sarcoidosis, Chagas disease
•
Symptoms:
•
progressive dysphagia; nocturnal regurgitation of food
•
Treatment: surgical myotomy with balloon dilation of LES
•
Sequelae:
•
5% develop squamous carcinoma
•
epiphrenic diverticulum, aspiration pneumonitis
23. Hiatal Hernia
•
•
•
•
•
Definition: pouch of proximal stomach extending >2cm
above diaphragmatic hiatus into thorax
Incidence: VERY COMMON, 15-50% adults (depending on
strictness of definition); incidence increases with age
Types
• Sliding: 95%; stomach and esophagus bulge through hiatus
together
• Paraesophageal: 5%; stomach alone herniates adjacent to
esophagus
Complications
• Reflux esophagitis (to be discussed)
• Incarceration: more likely in paraesophageal;
uncommon in sliding
Treatment: surgery for paraesophageal HH; degree of
morbidity determines medical vs. surgical therapy for sliding
24. Hiatal Hernia, sliding
type
Anatomy: widened space
between muscular crura of
diaphragm and wall of
esophagus
Pathogenesis: unknown;
possible congenital
weakness (some children
have HH) combined with
acquired defect
Symptoms: Only 10-20% of
adults with anatomically
demonstrable sliding HH have
“heartburn” (substernal pain
caused by regurgitation of
gastric juices into esophagus)
25. Lacerations (Mallory-Weiss
syndrome)
•
Def: linear lacerations in mucosa near EG junction
•
Pathogenesis: presumably mechanical trauma due to
prolonged retching; failure of E-G muscular relaxation
•
Risk factors: EtOH binges; prolonged vomiting
•
Pathology: mucosal defect of variable depth
•
Complications: mild to massive hemorrhage, ulceration or
perforation, mediastinitis, rarely rupture of esophagus
(Boerhaave syndrome)
•
Therapy: usually supportive because bleeding often stops
spontaneously. May need endoscopic coagulation, balloon
tamponade, or rarely surgery.
26. Mallory-Weiss laceration
Endoscopy: laceration straddling
the squamo-columnar junction
Surgical resection of distal esophagus
and proximal stomach for uncontrolled
hemorrhage caused by Mallory-Weiss
laceration
28. Reflux esophagitis
•
•
•
•
•
•
Def: mucosal injury secondary to reflux of acidic gastric
contents into lower esophagus; clinical term is GERD
(gastroesophageal reflux disease)
Incidence: 5% U.S. adults (millions of people!)
Clinical features: “heartburn”, chest pain mimicking MI,
regurgitation, dysphagia
Complications: ulceration, stricture, Barrett’s metaplasia
Pathogenesis: decreased LES tone or increased abdominal
pressure
Risk factors
• sliding hiatal hernia
• delayed gastric emptying ⇒ increased gastric volume
• obesity
• CNS depressant drugs; EtOH abuse, smoking
29. Histopathology of Reflux Esophagitis
Evidence of mild acute injury:
• Reactive squamous
hyperplasia • Scattered
eosinophils or neutrophils within
mucosa
PBD 8th ed, Elsevier 2010
More severe acute reflux injury:
mucosal ulceration
Evidence chronic reflux injury:
• basal zone hyperplasia (early)
• Barrett intestinal metaplasia
(later)
Chronic Reflux: hyperplastic basal
layer comprises > 20% of mucosal
thickness (normal basal layer is
< 20% of mucosal thickness)
30. • most commonly seen in immunocompromised patients
• three organisms comprise >90% esophageal infections
1) Candida:
Endoscopy shows
white patches
Silver stain:
pseudohyphae in
squamous mucosa
2) Herpes simplex, ground glass nuclei, intranuclear
inclusions in squamous cells, multinucleated cells
3) CMV, large intranuclear basophilic
inclusions in endothelial or stromal cells;
dot-like cytoplasmic inclusions
31. Infectious Esophagitis
•
most commonly seen in
immunocompromised patients
• three organisms comprise >90% esophageal
infections
1) Candida: Endoscopy shows white patches
Silver stain: pseudohyphae in squamous
mucosa
33.
3) CMV, large intranuclear basophilic inclusions in
endothelial or stromal cells; dot-like cytoplasmic
inclusions
34. Chemical/Physical Esophagitis
Causes:
Ethanol abuse,
heavy smoking
Acid or alkali
(accidental or
suicide attempt)
Very hot tea
Chronic uremia
Chemotherapy
Post-radiation
therapy for tumors
Post-arsenic ingestion
Post-radiation Therapy (stricture)
35. Eosinophilic Esophagitis
Path: abundant intraepithelial
eosinophils
Symptoms: dysphagia
(adults); reflux-like (children)
Associations: hypersensitivity
(atopic dermatitis, allergic
rhinitis, asthma)
Peripheral blood eosinophilia
Must prove absence of reflux
to make this diagnosis
Fig. 17-5B, PBD 8thth,2010
Fig. 17-5B, PBD 8 , 2010
36. Barrett esophagus (BE)
•
Definition (2 criteria):
•
•
•
(1) endoscopic evidence of abnormal mucosa above EG junction
(clinical criterion)
(2) intestinal metaplasia of squamous mucosa in biopsies of
esophagus (pathologic criterion)
Pathogenesis
•
Precise molecular mechanisms unclear
•
Acid reflux ⇒ inflammation⇒ chronic mucosal injury ⇒
metaplasia into more acid-resistant epithelium
•
Clinical: BE develops in 10-20% those with symptomatic chronic
reflux esophagitis; usually presents ages 40-60 after years of chronic
GERD.
•
MAJOR CONCERN: a minority of patients with BE develop epithelial
dysplasia which may progress into adenocarcinoma. Life-long risk
of adenocarcinoma is 10-15% in patients with BE, but this risk is
40x that of general population!
37. Barrett gross pathology: red granular mucosa
Metaplasia = gray hatched areas
Long segment (>3cm)
Short segment
(< 3cm, near EG jct)
Long segment
38. Natural History of Barrett Esophagus
Not completely predictable, but well-studied
• Four histopathologic categories predict risk for future
development of adenocarcinoma
• Negative for dysplasia (intestinal metaplasia only)
• Indefinite for dysplasia (unclear: inflammation or dysplasia)
• Low-grade dysplasia
• High-grade dysplasia
• Some things are known
• Low-grade dysplasia progresses to high-grade within 5 years in
10-30% patients. **
• Many low-grade dysplasias are not present on subsequent
endoscopic biopsies (regression or sampling error?) *
• High-grade dysplasia progresses to invasive adenocarcinoma in
30-60% patients within 5 years. **
•
* Sharma, Barrett’s Esophagus, NEJM 361:2548, 2009
** Spechler, Barrett’s Esophagus, NEJM
39. Barrett esophagus: histopathology 1
Diagnosis: intestinal
metaplasia, negative for
dysplasia
Diagnosis: intestinal metaplasia,
indefinite for dysplasia (reactive
inflammatory changes vs. lowgrade dysplasia
42. Esophageal Varices
•
Definition: permanently dilated submucosal veins
•
Pathogenesis
•
Normal venous circulation: GI tract to liver to inferior vena cava
•
Chronic portal venous hypertension ⇒ development of collateral
bypass channels (portal venous blood diverted into esophageal plexus,
then azygos veins, then superior vena cava)
•
Clinical setting: cirrhosis with portal venous hypertension
•
Clinical presentation
•
•
40% die during first bleeding episode
•
If survive first episode, 50% re-bleed in one year
•
•
No symptoms until varices rupture!!
Cause of death: hypovolemic shock ⇒ multi-organ failure
Rx: replace intravascular volume, give packed RBCs, stop bleeding
43. Esophageal varices: pathology
Dilated blue
varices
beneath intact
squamous
mucosa
Hemorrhage
secondary to
ruptured
varices
(KMC autopsy)
EG junction
44. Benign neoplasms & tumorlike lesions
•
Esophageal benign neoplasms are mostly of mesenchymal
origin (non-epithelial): leiomyomas, lipomas,
hemangiomas, neurofibromas.
•
Two distinctive lesions:
•
Fibrovascular polyp
•
Squamous papilloma
46. SquamousCell Carcinoma
•Mucosal epithelial dysplasia •Carcinoma
in situ •Invasive cancer
•Polypoidexophyticmasses that protrude
into the lumen; •Necrotizing cancerous
ulcerations that extend deeply and
sometimes erode into the respiratory tree,
aorta, or elsewhere; •Diffuse infiltrative
neoplasms
47.
A,Large ulcerated squamous cell carcinoma of the
esophagus. B,Low power view of cancer invasion of the
submucosa.
A
B
48. Adenocarcinoma
•Barrett esophagus is the only recognized
precursor of esophageal adenocarcinoma. •Large
nodular masses •Deeply ulcerative •Diffusely
infiltrative features •Mucin-producing glandular
tumors
Clinical Features
•Esophageal carcinoma is insidious in onset and
produces dysphagiaand obstruction gradually and
late. •Weight loss, anorexia, fatigue, and weakness
appear, followed by pain, usually related to
swallowing. •Diagnosis is usually made by imaging
techniques and endoscopic biopsy. •Surgical
excision is rarely curative. •Esophageal cancer
confined to the mucosa or submucosais amenable
to surgical treatment.
49. Fibrovascular polyp
Presentation: dysphagia; lesion usually in upper 1/3 esophagus
Histopathology:
abundant
vascularized
connective tissue
covered by
squamous mucosa
Is this a
neoplasm or
exuberant
hyperplasia?
50. Squamous papilloma
Low magnification: fronds of
thickened squamous epithelium
supported by connective tissue cores
Some have HPV-related cytologic
changes or evidence of HPV DNA
by in-situ hybridization methods
If squamous papilloma identified, respiratory tract should be
examined for HPV-related papillomatosis (especially children)
51. Malignant neoplasms of
esophagus: overview
Malignant tumors of esophagus comprise 6% of
all gastrointestinal cancers, but account for
10% GI cancer mortality
• Problem: often asymptomatic until late, when
they are deeply invasive or already metastatic
• Worldwide: 90% squamous / 10%
adenocarcinoma
• U.S.: 50% squamous / 50% adenocarcinoma;
incidence of adenocarcinoma rising
steadily since 1970, almost always arising in
Barrett esophagus
•
52. Squamous Carcinoma
Descriptor
Adenocarcinoma
M:F = 4:1; high incidence Iran,
China, Puerto Rico
(environmental initiators)
Epidemiology M:F = 7:1; >95% from
Initiators: environmental
carcinogens; promoters:
nutritional deficiencies
(vitamins A, B1, B2, B6, trace
metals)
Pathogenesis Barrett dysplasia:
Ethanol, tobacco, achalasia,
chronic esophagitis, PlummerVinson syndrome
Clinical Risk
Factors
chronic reflux
esophagitis
tobacco, obesity
20% upper third
50% middle third
30% lower third
Anatomic
Distribution
>95% lower third
5 yr. survival: 5-10%
--75% 5 yr. survival if T1 lesion
--25% 5 yr. survival for all
cases subjected to surgery
Prognosis
5 yr. survival: 25%
>80% 5 yr. survival with
esophagectomy for T1
lesion
Barrett metaplasia; <5%
from submucosal glands
early mutation or
overexpression of p53;
amplfication cERB-B2,
cyclin D, cyclin E
57. Adenocarcinoma: early invasive lesions
developing in setting of high grade dysplasia
High-grade dysplasia with
single dysplastic cell invading
lamina propria (intramucosal
adenocarcinoma = T1)
Adenocarcinoma invading submucosa,
T1 lesion (circled), arising in Barrett
intestinal metaplasia with high-grade
dysplasia (right half)
left photo courtesy University of Washington department pathology;
right photo courtesy University of Pittsburgh
58. Invasive Adenocarcinoma arising in Barrett esophagus
Intestinal metaplasia
with dysplasia (red)
Malignant glands invading into
submucosa (black)
Fig. 17-11B, Pathologic Basis of Disease, 7th ed, Elsevier 2005
Editor's Notes
Figure 3. Proposed Treatment Algorithm for Patients with Barrett's Esophagus.